InVivo Therapeutics Corp EV/EBIT
What is the EV/EBIT of InVivo Therapeutics Corp?
The EV/EBIT of InVivo Therapeutics Holdings Corp is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to InVivo Therapeutics Corp
What does InVivo Therapeutics Corp do?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Companies with ev/ebit similar to InVivo Therapeutics Corp
- Aurum Resources Ltd has EV/EBIT of N/A
- Aduro BioTech has EV/EBIT of N/A
- Quintana Services has EV/EBIT of N/A
- Maple Peak Investments has EV/EBIT of N/A
- Inovio Pharmaceuticals Inc has EV/EBIT of N/A
- Zoom Telephonics has EV/EBIT of N/A
- InVivo Therapeutics Corp has EV/EBIT of N/A
- Natures Hemp has EV/EBIT of N/A
- Pulmatrix Inc has EV/EBIT of N/A
- Techindia Nirman has EV/EBIT of N/A
- Larimar Therapeutics has EV/EBIT of N/A
- Epigenomics AG has EV/EBIT of N/A
- Internet of Things has EV/EBIT of N/A